TY  - BOOK
ED  - United States.
TI  - HIV prevention drug: billions in corporate profits after millions in taxpayer investments : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, May 16, 2019
AV  - KF27 .O96 2019i
PY  - 2019///
CY  - Washington
PB  - U.S. Government Publishing Office
KW  - Gilead Sciences (Firm)
KW  - Pre-exposure prophylaxis
KW  - Prices
KW  - United States
KW  - Cost control
KW  - HIV infections
KW  - Prevention
KW  - Prescription pricing
KW  - Government policy
KW  - Pharmaceutical industry
KW  - Medical policy
KW  - Federal aid to medical research
KW  - Legislative hearings
KW  - lcgft
N1  - "Serial no. 116-24."; CRDP Program record
UR  - https://purl.fdlp.gov/GPO/gpo124188
UR  - https://purl.fdlp.gov/GPO/gpo124189
ER  -